Form 4 holding
SVP, GEN COUNSEL AND SECRETARY
Theravance Biopharma, Inc.
- Security class
- Ordinary Shares
- Shares / value
- 355,168
- Estimated value
- $6,037,856
- Report date
- 20 Aug 2026
- Price
- $17.00
- Ownership
- Direct
Brett A. Grimaud - SVP, GEN COUNSEL AND SECRETARY at Theravance Biopharma, Inc.
Issuer-level insider activity
- Role
- Svp, Gen Counsel And Secretary
- Issuer ticker
- TBPH on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Brett A. Grimaud since 20 Sep 2025
Reported holdings for Brett A. Grimaud in Theravance Biopharma, Inc.
Transaction history for Brett A. Grimaud in Theravance Biopharma, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.